Dr. Ray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
New Orleans, LA 70121Phone+1 504-842-4015Fax+1 504-842-0098
Summary
- Dr. Arnab Ray is a gastroenterologist based in New Orleans, LA, specializing in gastrointestinal functional and motility disorders. He completed his medical education at Louisiana State University and his fellowship in gastroenterology at Ochsner Clinic Foundation. Dr. Ray has served as an attending physician at Ochsner Medical Center since 2012 and previously at Digestive Healthcare of Georgia Endoscopy Center. His expertise includes general gastroenterology, gastroesophageal reflux, Recurrent C. difficile infection, esophageal disease, and celiac disease. He has contributed to multiple publications in reputable journals and conducted clinical trials focused on microbiota restoration therapy for recurrent Clostridioides Difficile-associated diarrhea. Dr. Ray received the Governor’s Award for Excellence in Clinical Research from the American College of Gastroenterology in 2013.
Education & Training
- Ochsner Clinic FoundationFellowship, Gastroenterology, 2007 - 2010
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2004 - 2007
- Louisiana State University School of Medicine in New OrleansClass of 2004
- Rice UniversityBA, Biochemistry and History, 1996 - 2000
- Benjamin Franklin High SchoolHigh School, 1992 - 1996
Certifications & Licensure
- LA State Medical License 2007 - 2024
- GA State Medical License 2010 - 2013
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Governor’s Award for Excellence in Clinical Research - Fecal Microbiota Transplantation (FMT) for Treatment of Clostridium difficile infection (CDI) in Immmunocompromised Patients American College of Gastroenterology, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 1 citationsFuture Microbiome Therapeutics for Clostridioides difficile Infection.Monika Fischer, Arnab Ray
The American Journal of Gastroenterology. 2024-01-01 - 3 citationsInterplay of Trapped Species and Absence of Electron Capture in Moiré Heterobilayers.Arnab Barman Ray, Arunabh Mukherjee, Liangyu Qiu, Renee Sailus, Sefaattin Tongay
Nano Letters. 2023-07-12 - 5 citationsCross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension.Yuanjun Shen, Dmitry A Goncharov, Andressa Pena, Jeffrey Baust, Andres Chavez Barragan
Science Signaling. 2022-12-06
Journal Articles
- Overview of the Management of Clostridium difficile infectionsRay, A, Garcia Diaz, J Rivera Rivera, K, Infectious Disease Special Edition, Gastroenterology Special Edition, 2014
- Histoplasmosis presenting as a hypopharyngeal mass in an immune compromised hostRay, A. Gahunia, M., Practical Gastroenterology, 10/2010
- HSV-1 Migration in Latently Infected and Naïve Rabbits Following Penetrating KeratoplastyZheng, Marquart, Loutsch, Shah, Sainz, Ray, O’ Callaghan, Kaufman, Hill, Invest. Ophthalmol. Vis. Sci, 10/1/1999
Abstracts/Posters
- Results of the Phase 2 Punch CD Safety Study of RBX2660 (microbiota suspension) for Recurrent Clostridium difficile InfectionDubberke, Orenstein, Mullane, Hardi, Ray, Sobcinski, ECCMID, Denmark, 4/1/2015
- RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: Lessons Learned from the PUNCH CD StudyRay, Hardi, Ramesh, Sobcinski, ACG 2014, Philadelphia, 10/1/2014
- RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH CD Phase 2 Safety StudyRamesh, Misra, Ray, Smith, Sobcinski, ACG, Philadelphia, 10/1/2014
- Join now to see all
Lectures
- Achalasia Management - Endoscopic Dilation/Botox is the Way to Go” “Pathologic Gastroesophageal Reflux Disease - Chronic Medical Therapy is OK”Pharyngoesophageal Dysfunction and Gastroesophageal Reflux Symposium. CME Conference - 9/2014
- Celiac DiseaseHello Health Television Show - 12/2013
- Making Sense of ProbioticsOchsner Resident and Fellow Conference - 4/2013
- Join now to see all
Press Mentions
- Your Comprehensive Guide to Colon CancerJuly 14th, 2021
- ‘Class of the First Oath’ Addresses Health Care Disparities, Social Justice IssuesSeptember 23rd, 2020
- ‘Foundational Knowledge’: School of Medicine Reflects on Anti-Racist Curriculum ChangesJuly 15th, 2020
- Join now to see all
Grant Support
- Safety and Efficacy of Fecal Microbiota Transplant in Mild to Moderate Ulcerative ColitisOchsner Translational Medicine Research Initiative2014–Present
Professional Memberships
- Member
External Links
- Ochsner Department of Gastroenterology Websitehttp://www.ochsner.org/services/digestive_disorders_gastroenterology1/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: